SCHEMBL18484186

SCHEMBL18484186

CCSc1cc(C(=O)O)c2ncccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
PDE4A P27815 1/20 0.45
KDM4E B2RXH2 6/20 0.43
HPGD P15428 4/20 0.43
HSD17B10 Q99714 4/20 0.43
LMNA P02545 1/20 0.43
ALOX12 P18054 1/20 0.43
PARP1 P09874 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HSP90AA1 P07900 1/20 0.41
RAB9A P51151 1/20 0.41
TP53 P04637 2/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14820315 0.84 MEN1 (0.53) ALDH1A1PDE4AKDM4ELMNAALOX12
SCHEMBL18484428 0.80 ALDH1A1 (0.47) ALDH1A1PDE4AKDM4ELMNAALOX12
SCHEMBL29923343 0.79 PARP1 (0.52) ALDH1A1PDE4AKDM4EHSD17B10LMNA
SCHEMBL21816294 0.77 PSMD14 (0.56) ALDH1A1KDM4ELMNAALOX12PARP1
SCHEMBL68215 0.75 ALDH1A1 (0.54) ALDH1A1PDE4AKDM4ELMNAALOX12
SCHEMBL30605381 0.75 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAALOX12PARP1
SCHEMBL11429773 0.75 ALDH1A1 (0.58) ALDH1A1KDM4ELMNAALOX12PARP1
SCHEMBL29089214 0.75 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAALOX12PARP1
SCHEMBL4602037 0.74 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAALOX12PARP1
SCHEMBL8544466 0.74 ALDH1A1 (0.53) ALDH1A1KDM4EHSD17B10LMNAALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170037059-A1 GYRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170037059-A1 GYRASE INHIBITORS TOP1, CA7, TOP2B ALDH1A1 2837/4885PDE4A 3148/4885KDM4E 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.